Actuate Therapeutics, Inc. Share Price
NASDAQ: ACTU | Micro CapActuate Therapeutics, Inc. Stock Performance
Actuate Therapeutics, Inc. Share Price Today
As of 30 October 2026, Actuate Therapeutics, Inc.'s share price is $0.37. The stock opened at $0.38, compared to its previous close of $0.38. During today's trading session, Actuate Therapeutics, Inc.'s share price traded between $0.37 and $0.39, with an average price of $0.38. Over the past 52 weeks, the stock has recorded a high of $7.80 and a low of $0.36. In terms of performance, Actuate Therapeutics, Inc.'s share price has declined by 87.27% over the last six months and is down 94.45% on a year-on-year basis.
Actuate Therapeutics, Inc. Share Price Chart
Actuate Therapeutics, Inc. Quarterly Profit & Loss
All figures in USD
Actuate Therapeutics, Inc. Annual Profit & Loss
All figures in USD
About Actuate Therapeutics, Inc.
Actuate Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing therapies for the treatment of high impact, difficult to treat cancers through the inhibition of glycogen synthase kinase-3 (GSK-3). It is developing elraglusib (formerly 9-ING-41), a small molecule that is designed to enter cancer cells and block the function of the enzyme GSK-3B, a master regulator of complex biological signaling cascades, including those mediated by oncogenes, that lead to tumor cell survival, growth, migration, and invasion.
Actuate Therapeutics, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Oct 2026 | $0.86 | $0.37 | -53.40% |
Sep 2026 | $1.45 | $0.79 | -53.84% |
Aug 2026 | $1.12 | $1.72 | +54.26% |
Jul 2026 | $1.50 | $1.11 | -25.67% |
Jun 2026 | $2.21 | $1.50 | -25.74% |
May 2026 | $3.10 | $2.02 | -30.58% |
Apr 2026 | $2.83 | $2.91 | +6.99% |
Mar 2026 | $3.60 | $2.72 | -28.42% |
Feb 2026 | $4.92 | $3.80 | -19.83% |
Jan 2026 | $6.01 | $4.74 | -22.30% |
Dec 2025 | $7.23 | $6.10 | -19.21% |
Nov 2025 | $6.52 | $7.55 | +13.19% |